Literature DB >> 16062093

Botulinum toxin and intractable trigeminal neuralgia.

Ulkü Türk1, Selen Ilhan, Recep Alp, Haydar Sur.   

Abstract

The effects of botulinum toxin have been demonstrated in pain syndromes such as migraine, tension headache, and postherpetic neuralgia. With this background data in hand, the authors planned a randomized, open-ended study to investigate the efficacy of botulinum injections in cases of refractory trigeminal neuralgia. In 8 patients with trigeminal neuralgia, 100 U botulinum toxin was injected into the region of the zygomatic arch. The results of their statistical analyses demonstrated that the medication can be effective in treating trigeminal neuralgia. The patients did not develop any significant adverse effects. Botulinum toxin can be used in the treatment of refractory trigeminal neuralgia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16062093     DOI: 10.1097/01.wnf.0000172497.24770.b0

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  24 in total

1.  A new target for the treatment of trigeminal neuralgia with botulinum toxin type A.

Authors:  Chuanjie Wu; Nanchang Xie; Hongbo Liu; Haifeng Zhang; Lu Zhang; Yajun Lian
Journal:  Neurol Sci       Date:  2017-10-30       Impact factor: 3.307

Review 2.  Refractory trigeminal neuralgia. Non-surgical treatment options.

Authors:  Giorgio Cruccu; Andrea Truini
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

3.  Diagnostic value of some less frequently considered blink reflex parameters in idiopathic trigeminal neuralgia.

Authors:  Ivan Mikula; Snježana Miškov; Vesna Serić; Jelena Bošnjak
Journal:  Wien Klin Wochenschr       Date:  2011-11-04       Impact factor: 1.704

Review 4.  Botulinum Toxin for Neuropathic Pain: A Review of the Literature.

Authors:  Hyun-Mi Oh; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2015-08-14       Impact factor: 4.546

Review 5.  Current status and future directions of botulinum neurotoxins for targeting pain processing.

Authors:  Sabine Pellett; Tony L Yaksh; Roshni Ramachandran
Journal:  Toxins (Basel)       Date:  2015-11-04       Impact factor: 4.546

6.  Successful treatment of a resistance trigeminal neuralgia patient by acupuncture.

Authors:  Hüseyin Sert; Burhanettin Usta; Bünyamin Muslu; Muhammet Gözdemir
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

7.  An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions.

Authors:  Ricardo Persaud; George Garas; Sanjeev Silva; Constantine Stamatoglou; Paul Chatrath; Kalpesh Patel
Journal:  JRSM Short Rep       Date:  2013-02-12

Review 8.  Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.

Authors:  Siro Luvisetto; Parisa Gazerani; Carlo Cianchetti; Flaminia Pavone
Journal:  Toxins (Basel)       Date:  2015-09-23       Impact factor: 4.546

Review 9.  Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.

Authors:  Yong Hu; Xiaofei Guan; Lin Fan; Mu Li; Yiteng Liao; Zhiyu Nie; Lingjing Jin
Journal:  J Headache Pain       Date:  2013-08-21       Impact factor: 7.277

Review 10.  Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia.

Authors:  Gaurav Verma
Journal:  Pain Res Treat       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.